WEBSITE PRIVACY STATEMENT

At Cephalon, we understand that numerous laws and regulations around the world govern data protection and we respect the fact that protecting your privacy is important to you. We also recognize that health and medical information is particularly sensitive. For those reasons, we want to explain our Internet privacy policy to you in this Website Privacy Statement. Please review this Statement to learn about how Cephalon collects, uses, shares and protects information.

First and foremost, however, we only collect your personal information you if you choose to give it to us. Cephalon may share you personal information with various outside companies or agents working on our behalf to help fulfill business transactions, and we also may share personal information with our company’s affiliates. However, we do not share any of your personal information with third parties for their own marketing use unless you explicitly give us permission to do so.

This Website Privacy Statement applies only to personal information collected online from the various websites of Cephalon. Other Cephalon privacy policies govern personal information that is not collected on Cephalon websites.

INFORMATION COLLECTED - INFORMATION YOU GIVE US

At our web sites, we only collect your personal information (such as your name, address, telephone number or e-mail address) when you choose to submit it to us. For example, you may choose to register to receive additional product information or information about a disease state that interests you.

In some cases, we remove personal identifiers from data and maintain it in aggregate form. We may combine this data with other information to produce anonymous, aggregated statistical information helpful to us in improving our products and services.

AUTOMATICALLY COLLECTED INFORMATION

We automatically collect certain types of information whenever you interact with us on our sites and in some e-mails we may send each other. Automatic technologies we use may include, for example, web server logs and IP addresses, cookies and web beacons.

Web Server Logs and IP Addresses: An IP address is a number assigned to your computer whenever you access the Internet that allows computers and servers to recognize and communicate with each other. Cephalon collects IP addresses to conduct system administration and report aggregate information to affiliates, business partners, service providers and/or vendors to conduct web site analysis and performance reviews.

Cookies: A cookie is a piece of information that is placed on your computer when you access certain web sites. The cookie uniquely identifies your browser to the server. Cookies allow us to store information on the server to help make your web experience better and to conduct web site analysis and performance reviews. Most web browsers are set up to accept cookies, although you can reset your browser to refuse all cookies or to indicate when a cookie is being sent. Note, however, that some portions of our sites may not work properly if you refuse cookies.

Web Beacons: On certain web pages or e-mails, Cephalon may utilize a common Internet technology called a “web beacon” (also known as an “action tag” or “clear GIF technology”). Web beacons help analyze the effectiveness of web sites by measuring, for example, the number of visitors to a site or how many visitors clicked on key elements of a site.

Web beacons, cookies and other tracking technologies do not automatically obtain personal information about you. Only if you voluntarily submit personal information, such as by registering or sending e-mails, can these automatic tracking technologies be used to provide further information about your use of the web sites to improve their usefulness to you.

YOUR CHOICES

You have certain options regarding your use of our sites. Cephalon may require you to provide certain personal information in order for you to receive additional product information or information about a disease state. You could decide not to submit any personal information at all by not entering it into any forms or data fields on our sites and not using any available personalized services. Certain web sites may ask for your permission for certain uses of your personal information and you can agree to or decline those uses. If you opt-in for particular services or communications, such as an e-newsletter, you will be able to unsubscribe at any time by following the instructions included in each communication. If you decide to unsubscribe from a service or communication, we will work to remove your information promptly, although we may require additional information before we can process your request.

As described above, if you wish to prevent cookies from tracking you anonymously as you navigate our sites, you can reset your browser to refuse all cookies or to indicate when a cookie is being sent. Note, however, that some portions of our sites may not work properly if you refuse cookies.

USE OF PERSONAL INFORMATION

Cephalon and/or the service providers, vendors and other third parties we hire to perform services on our behalf may use any personal information you choose to give us to comply with your requests or as otherwise disclosed to you in this Website Privacy Statement or on the web page where you submit your information to us. We may refer to this information to better understand your needs and how we can improve our products and services.

We use aggregated information collected from our websites to help us understand trends and customer needs. For example, we may analyze the gender or age of visitors to sites about a particular medication or disease state, and we may use that analysis of aggregate data internally or share it with others.

DATA SHARING AND TRANSFER

Cephalon may share personal information about you with various outside companies or service providers or vendors working on our behalf to help fulfill business transactions, such as providing customer service, sending marketing communications about our products, services and offers, and doing technological maintenance. We may also share personal information with our company’s affiliates.

We may also disclose personal information for these purposes:

  1. in connection with the sale, assignment or other transfer of the business of the site to which the data relates;
  2. to respond to requests of government or law enforcement agencies or where required or permitted by applicable laws, court orders, or government regulations; or
  3. where needed for corporate audits or to investigate or respond to a complaint or security threat.

No Third-Party Direct Marketing Use: Cephalon will not sell or otherwise transfer the personal information you provide to us at our sites to any third parties for their own direct marketing use unless we provide clear notice to you and obtain your explicit consent for your data to be shared in this manner.

E-mail a Friend or Colleague: On some Cephalon sites, you can choose to send a link or a message to a friend or colleague referring them to a Cephalon web site. The e-mail addresses you may provide for a friend will be used to send your friend information on your behalf and will not be collected or used by Cephalon or other third parties for additional purposes.

Note to Users of Business or Professional Web Sites: If you have a business or professional relationship with Cephalon, we may use information you submit on our sites, including sites intended specifically for business and professional users, to fulfill your requests and develop our business relationship with you and the entities you represent. We may also share such information with third parties acting on our behalf.

LINKS TO OTHER SITES

Our sites contain links to a number of web sites that may offer useful information to our visitors. This Website Privacy Statement does not apply to those sites, and we recommend communicating with them directly for information on their privacy policies.

PRIVACY STATEMENT FOR CHILDREN UNDER 13

Cephalon does not knowingly collect or solicit personal information from anyone under the age of 13 or knowingly allow such persons to register on our websites. Our sites are not intended or designed to attract children under the age of 13. No one under age 13 is allowed to provide any personal information to Cephalon. If you are under 13, please do not send any information about yourself to Cephalon, including your name, address, telephone number, or email address. In the event that we learn that we have collected personal information from a child under age 13, we will delete that information as quickly as possible. If you believe that we might have any information from or about a child under 13, please contact us at globalprivacy@cephalon.com and we will delete such information.

ADDITIONAL INFORMATION ON WEB SITES

If a Cephalon web site has particular provisions relating to privacy that differ from those stated here, those provisions will be disclosed to you on the page on which your personal information is collected.

UPDATES TO WEBSITE PRIVACY STATEMENT

From time to time, Cephalon may revise this Website Privacy Statement. Any such changes will be promptly communicated on Cephalon’s websites. Continued use of our sites after receiving notice of a change in our Website Privacy Statement indicates your consent to the use of newly submitted personal information in accordance with the amended Website Privacy Statement.

HOW TO CONTACT CEPHALON

If you have any questions about Cephalon’s Website Privacy Statement or the information practices of our sites, you may contact us as follows:

Cephalon, Inc.
41 Moores Road
PO Box 4011
Frazer, PA 19355
610-344-0200
globalprivacy@cephalon.com


Effective Date: May 9, 2008

Important Safety Information

What is NUVIGIL?

NUVIGIL is a prescription medicine used to improve wakefulness in adults who experience excessive sleepiness (ES) due to one of the following diagnosed sleep disorders: obstructive sleep apnea (OSA), shift work sleep disorder, or narcolepsy.

In patients with OSA, NUVIGIL is used along with other medical treatments for this sleep disorder. NUVIGIL is not a replacement for your current treatment. Consult your doctor about the importance of continuing your current OSA treatment while taking NUVIGIL.

NUVIGIL is a federally controlled substance (C-IV) because it has the potential to be abused or lead to dependence. Please use NUVIGIL only as directed and keep in a safe place to prevent misuse and abuse.

What important information should I know about NUVIGIL?

  • NUVIGIL may cause you to have a serious rash or a serious allergic reaction that may result in hospitalization or be life-threatening.
  • If you develop a rash, hives, sores, swelling, or trouble swallowing or breathing, stop taking NUVIGIL and call your doctor right away or get emergency treatment.

Who should not take NUVIGIL?

  • NUVIGIL has not been studied in children under the age of 17. NUVIGIL is not approved for children for any condition.
  • Anyone who has had a rash or allergic reaction to NUVIGIL or PROVIGIL® (modafinil) Tablets [C-IV], or is allergic to any of the following ingredients: modafinil, armodafinil, croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose, povidone, or pregelatinized starch.
  • Anyone with mitral valve prolapse who has experienced mitral valve prolapse syndrome.

What are possible side effects of NUVIGIL?

  • Common side effects of NUVIGIL are headache, nausea, dizziness, and trouble sleeping.
  • If you experience chest pain, depression, anxiety, hallucinations, psychosis, mania, thoughts of suicide, aggression, or other mental problems, stop taking NUVIGIL and call your doctor right away or get emergency treatment.
  • For more information about other side effects, ask your doctor or pharmacist.

What should I avoid while taking NUVIGIL?

  • Do not drive a car or do other dangerous activities until you and your doctor know how NUVIGIL affects you.
  • Avoid drinking alcohol.

What should I tell my doctor before starting NUVIGIL?

  • Tell your doctor about all of your health conditions including if you have: history of mental health problems (including psychosis), heart problems or had a heart attack, high blood pressure, liver or kidney problems, a history of drug or alcohol abuse or addiction, or are pregnant, planning to become pregnant, or breastfeeding.
  • Women who use hormonal birth control may have a higher chance of getting pregnant, while taking NUVIGIL, and for one month after stopping. Talk to your doctor about other birth control methods while taking NUVIGIL.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, call 1-800-FDA-1088, or by fax at 1-800-FDA-0178.

For more information, ask your doctor or call 1-800-896-5855.

This information does not take the place of talking with your doctor about your condition or treatment.

Please see the Patient Information in the full prescribing information for NUVIGIL.